LE, H., T, B., X, X., L, G., EA, R., D, B., . . . L, J. (2025). Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL1331 trial. Haematologica, 110(12), 2930. https://doi.org/10.3324/haematol.2025.287386
Chicago Style (17th ed.) CitationLE, Hogan, et al. "Severe Toxicity and Poor Efficacy of Reinduction Chemotherapy Are Associated with Overall Poor Outcomes in Relapsed B-cell Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group AALL1331 Trial." Haematologica 110, no. 12 (2025): 2930. https://doi.org/10.3324/haematol.2025.287386.
MLA (9th ed.) CitationLE, Hogan, et al. "Severe Toxicity and Poor Efficacy of Reinduction Chemotherapy Are Associated with Overall Poor Outcomes in Relapsed B-cell Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group AALL1331 Trial." Haematologica, vol. 110, no. 12, 2025, p. 2930, https://doi.org/10.3324/haematol.2025.287386.
